HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Triethanolamine

This article was originally published in The Rose Sheet

Executive Summary

National Toxicology Program Board of Scientific Counselors will meet Oct. 30 to re-review draft technical reports of five two-year studies, including the draft report on triethanolamine that had been reviewed in 1994 and showed TEA's "equivocal," or uncertain, carcinogenicity. The re-review was scheduled due to the discovery of Helicobacter hepaticus infection in male mice. The reviewers are expected to find the study "inadequate." The meeting begins at 9 a.m. at the National Institute of Environmental Health Sciences in Research Triangle Park, N.C

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005899

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel